SHARON NACHMAN MD.

Department:
STONY BROOK CHILDREN'S SERVICE

Board Certification:
Pediatrics
Pediatric Infectious Diseases

Gender:
Female

Best Doctor Lists
New York Magazine's Best Doctors
Top Doctors: New York Metro Area
BestDoctors.com

Primary Medical Conditions Treated:

AIDS (HUMAN IMMUNODEFICIENCY VIRUS (HIV))
CHRONIC FATIGUE SYNDROME
EPIDEMIOLOGY
FLU (FLU VACCINATION), IMMUNIZATIONS
HEPATITIS
HIV (HUMAN IMMUNODEFICIENCY VIRUS (HIV))
IMMUNOLOGY
INFECTIOUS
INFECTIOUS DISEASES
LYME DISEASE
PEDIATRIC HIV
PEDIATRIC INFECTIOUS DISEASES
PNEUMOCOCCAL DISEASES
PNEUMONIA
RESEARCH TRIALS (CLINICAL TRIALS)
STD (SEXUALLY TRANSMITTED DISEASES (STDS) IN WOMEN)
TUBERCULOSIS

Education and Training

Medical School:
Stony Brook University School of Medicine, New York

Residency:
Schneiders Children's Hospital of Long Island Jewish Medical Center

Fellowship:
New York Medical College Valhalla, New York; The Rockefeller University

Academic

Year Appointed at Stony Brook:
1990

Honors, Awards and Grants:
(1)Research & Scholarship Award 2007: SUNY Research Foundation (2) Fellow, American Academy of Pediatrics (3) Fellow, American Society of Microbiology (4)Alumni of the Year: Stony Brook University School of Medicine 2004 (5)American Medical Women's Association: Changing the Face of Medicine: Local Legends Award 2003 (6)Excellence in Teaching Pediatric Residents SUNY Stony Brook 2003, 2002, 2001 (7)Distinguished Graduate Alumni Award: SUNY Stony Brook 1997 (8)Alpha Omega Alpha (AOA) election 1996 (9)Three Village Woman of the Year in Medicine 1993 (10)Brookhaven Town Woman of the Year in Medicine 1992

Academic Rank:
Professor

Insurance Plans

AETNA
AFFINITY HEALTH PLAN
AMERICHOICE
ANTHEM
APA PARTNERS
BEECH STREET
BLUE CROSS/BLUE SHIELD HMO
BLUE CROSS/BLUE SHIELD OTHER PLANS
BLUE CROSS/BLUE SHIELD PPO
BLUE CROSS/BLUE SHIELD SENIOR PLAN
CIGNA HMO
CIGNA PPO
DEVON HEALTH
EMPIRE PLAN
FIDELIS CARE NEW YORK
FIRST HEALTH
GHI CBP
GHI HMO
GREAT WEST HEALTHCARE
HEALTH NET
HEALTHFIRST
HEALTHNET FEDERAL SERVICES (TRICARE)
HIP
ISLAND GROUP ADMINISTRATION
MAGNACARE
MEDICAID
MEDICARE
MULTIPLAN
OXFORD FREEDOM PLAN
SUFFOLK HEALTH PLAN
UNITED HEALTHCARE
US FAMILY HEALTH PLAN
VYTRA (except SMART START)

Practice Sites

PEDIATRICS,
UNIVERSITY MEDICAL CENTER L5,
NICOLLS ROAD,
STONY BROOK, NY 11794-7564.

Ph.: 631-444-KIDS
Fax

Fax: 631-444-6016

PEDIATRICS,
225 W MONTAUK HWY,
HAMPTON BAYS, NY 11946.

Ph.: 631-444-KIDS
Fax

Fax: 631-723-5010

My Notes

Director, Division of Pediatric Infectious Diseases and Director of the Office of Clinical Trials. Principal investigator of dozens of clinical trials of promising medicines for patients treated at the Medical Center. These include at least 10 international trials, in areas such as new vaccines, Lyme Disease, and AIDS. She also heads the Maternal Child HIV/AIDS Program.

My Articles

(1)L.C. Floren, A. Wiznia, S. Hayashi, A. Jayewardene, K. Stanley, G. Johnson, S. Nachman, P. Krogstad, F.T. Aweeka, and the Pediatric AIDS Clinical Trials Group 377 Team. Nelfinavir pharmacokinetics in stable HIV-positive children: PACTG 377. Pediatrics 2003;112(3):e220-e227. (2)L.J. Grando, L.S. Yurgel, D.C. Machado, S. Nachman, F. Ferguson, B. Berentsen, A. Fernandes. Associa��o entre manifesta��es estomatol�gicas e caractyer�sticas socioeconimicas e culturais de crian�as brasileiras e norte-americanas infectadas pelo HIV. Pan Am J Public Health 2003;14(2):112-118. (3)D.M. Gaughan, M.D. Hughes, J.M. Oleske, K. Malee, S. Nachman, for the PACTG 219C Team. Psychiatric hospitalizations in pediatric HIV disease. Pediatrics 2004;113(6):e544-e551. (4)J. Hitti, L.M. Frenkel, A.M. Stek, S.A. Nachman, D. Baker, A. Gonzalez-Garcia, A. Provisor, E.M. Thorpe, M.E. Paul, M. Foca, J. Gandia, S. Huang, L.J. Wei, L.M. Stevens, D.H. Watts, J. McNamara, for the PACTG 1022 Study Team. Maternal toxicity with continuous nevirapine in pregnancy: Results from PACTG 1022. J Acquir Immune Defic Syndr 2004;36(3):772-776. (5)C.V. Fletcher, R. Yogev, S.A. Nachman, A. Wiznia, S. Pelton, K. McIntosh, and K. Stanley. Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection. Pharmacotherapy 2004;24(4):453-9.